For the Inventor, By the Inventor

Enter assignee name

Baltimore, MD, United States of America

Agenebio, Inc.

Calculating rank

USPTO Granted Patents = 16

% Expired Patents = 18.8

CIPO Patents = 2

EPO Patents = 8

Forward Citations = 66

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Belew Mekonnen (10 out of 11 patents)

Jianxing Huang (10 out of 13 patents)

John Anthony Butera (10 out of 59 patents)

4. Hemantbhai Patel (5 out of 8 patents)

5. Qin Jiang (2 out of 15 patents)

6. Robert Jason Herr (2 out of 19 patents)

7. Emily Elizabeth Freeman (2 out of 24 patents)

8. Nicholas James Mayhew (2 out of 5 patents)

9. Michela Gallagher (2 out of 7 patents)

10. Elsie Melsopp (2 out of 2 patents)

11. Jack Lawrence James (2 out of 4 patents)

12. Sharon J Rosenzweig-Lipson (2 out of 15 patents)

13. John Adams Lowe, Iii (2 out of 83 patents)

14. Travis Lee Houston (1 out of 27 patents)

15. Stephan D Parent (1 out of 53 patents)

16 patents: Sort by Forward Citations

1. 12774283 - Polymorphs of a GABAα5 agonist and methods of using in the treatment of cognitive impairment (2026-10-27),

2. 12760030 - Benzazepine derivatives, compositions, and methods for treating cognitive impairment (2026-10-13),

3. 12528819 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2026-01-20),

4. 12291535 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2025-05-06),

5. 12024525 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2024-07-02),

6. 11505555 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2022-11-22),

7. 11414425 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2022-08-16),

8. 11312721 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2022-04-26),

9. 11160785 - Methods and compositions for improving cognitive function (2021-11-02),

10. 11142529 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2021-10-12),

11. 10925834 - Extended release pharmaceutical compositions of levetiracetam (2021-02-23),

12. 10815242 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2020-10-27),

13. 10329301 - Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment (2019-06-25),

14. 10159648 - Extended release pharmaceutical compositions of levetiracetam (2018-12-25),

15. 9801879 - Pyridazine derivatives, compositions and methods for treating cognitive impairment (2017-10-31),

Company Overview

Agenebio, Inc. is a biotechnology company based in Baltimore, MD, specializing in the development of innovative solutions for the healthcare sector. The organization focuses on advancing therapeutic and diagnostic technologies, particularly in the realm of genetic and molecular medicine. By leveraging cutting-edge research, Agenebio aims to address unmet medical needs and improve patient outcomes through its proprietary platforms and products. The company is committed to fostering advancements in personalized medicine and enhancing the understanding of complex diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

16 Patents

#32 in Baltimore, MD

#276 in Maryland

#19,966 in US

#37,952 in the World

Baltimore, MD, United States of America

Agenebio, Inc.

Forward Citations = 66

18 inventors:

Belew Mekonnen (10 out of 11 patents)

Jianxing Huang (10 out of 13 patents)

John Anthony Butera (10 out of 59 patents)

4. Hemantbhai Patel (5 out of 8 patents)

5. Qin Jiang (2 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Agenebio, Inc.. Retrieved from https://idiyas.com/company/agenebio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…